CD163 is also involved in regulating the role of CK2 in glioma stemness by interacting with CK2β, leading to an increase in phosphorylation of AKT, GSK-3β/β-catenin pathway activity, inappropriate cell cycle progression, and glioma proliferation [68]. The gene discussed is GSK3B; the disease is glioma.